Optimising the Delivery of Stroke Care

The development of innovative ultrasound imaging equipment within the UMEDS project aims to provide for mobile stroke detection. When linked to advanced telemedicine systems, such diagnostic equipment could offer valuable information to guide prehospital thrombolysis.

In patients with acute cerebral ischemia, brain perfusion can be analysed by means of different diagnostic techniques, including computed and magnetic resonance tomography among others. However, it is the continuous development of non-invasive ultrasound techniques that has provided invaluable clinical applications for the assessment of intracranial arterial diseases.

Ultrasound can be utilised at the bedside for critically ill patients and provide timely information on arterial dissection and occlusion of brain arteries, as well as embolic occlusion. The concept of ultrasound perfusion analysis was not new; but the ability to estimate perfusion parameters with accuracy has only been made possible with recent developments in ultrasonographic imaging techniqes.

Localisation of specific biochemical epitopes with targeted contrast agents afforded the opportunity for imaging thrombus material in acute vessel occlusions. It also provides an effective means for the detection of micro-embolic signals. Moreover, software development at the INSERM laboratories in France has allowed rapid electronic transfer of data from the detector arrays and rapid image reconstruction for subsequent perfusion analysis.

Studies were undertaken to ascertain the optimal delivery mode of microbubbles with antibodies to activate platelets for targeted imaging, and the results were integrated into the image analysis software. The new software supports the automatic factor analysis of medical image sequences (FAMIS), along with the conventional parametric analysis of temporally arranged sequences.

To minimise respiratory motion artefacts in ultrasound contrast imaging sequences, and furthermore to improve parametric and FAMIS imaging from time sequences, dedicated software developed in MATLAB was added. The software package, readily available on a CD-ROM, can be implemented either step-by-step under the permanent supervision of the user or automatically both for clinical and pharmaceutical research applications.

For further information, please visit:

Copyright ©European Communities, 2008
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...